164 related articles for article (PubMed ID: 860916)
1. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
Fedeli S; Maglia A
Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
[TBL] [Abstract][Full Text] [Related]
2. Behaviour of the IRI plasmatic level in diabetic subjects after intravenous injection of tolbutamide.
Artenisio AC; Albanese MC; Allegra V; Sprovieri M; Alibrando S; Ragonese F; Corsi V
Folia Endocrinol; 1974 Oct; 27(5):439-62. PubMed ID: 4480627
[No Abstract] [Full Text] [Related]
3. [Immunoreactive insulin, nonesterified fatty acids and glucose in the serum following intravenous administration of glibornuride as compared to tolbutamide].
Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
Verh Dtsch Ges Inn Med; 1971; 77():556-9. PubMed ID: 5155896
[No Abstract] [Full Text] [Related]
4. Glipizide and hepatic glycogenolysis.
Bloch K; Daturi S; Tommasini R
Acta Endocrinol Suppl (Copenh); 1980; 239():11-4. PubMed ID: 7001838
[TBL] [Abstract][Full Text] [Related]
5. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
6. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
Kirti S; Dutta PK; Vaishnava H; Singh RB
J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
[No Abstract] [Full Text] [Related]
7. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
Ulrich E; Frank I; Kujat G; Müller G; Seige K
Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
[No Abstract] [Full Text] [Related]
8. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
Göschke H; Denes A; Girard J; Collard F; Berger W
Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
[No Abstract] [Full Text] [Related]
9. [Levels of basal insulinemia and changes of the plasmatic concentration of nonesterified fatty acids (NEFA) and of blood sugar after administration of tolbutamide in obese children].
Iafusco F; Pierantoni G; Stoppoloni G; Pacelli V
Pediatria (Napoli); 1967; 75(5):780-8. PubMed ID: 5603123
[No Abstract] [Full Text] [Related]
10. Glipizide: experimental study and comparison with other sulfonylureas.
Loubatieres-Mariani MM
Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
[No Abstract] [Full Text] [Related]
11. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
[TBL] [Abstract][Full Text] [Related]
13. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
[TBL] [Abstract][Full Text] [Related]
14. A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects.
Ceretti AP; Losi S; Orsini G; Emanueli A
Arzneimittelforschung; 1975 Apr; 25(4):675-6. PubMed ID: 808231
[TBL] [Abstract][Full Text] [Related]
15. Influence of glipizide on hepatic and peripheral insulin exchange after glucose administration.
Nygren A; Sundblad L; Wiechel KL
Acta Endocrinol Suppl (Copenh); 1980; 239():15-8. PubMed ID: 7001839
[TBL] [Abstract][Full Text] [Related]
16. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
[No Abstract] [Full Text] [Related]
17. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
[TBL] [Abstract][Full Text] [Related]
18. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Groop L; Tötterman KJ
Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
[TBL] [Abstract][Full Text] [Related]
19. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
20. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
Pedrazzi F; Bommartini F; Freddo J; Emanueli A
Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
